Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...
Microbix Further Optimizes Capital Usage and Availability
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, announces the further optimization of the structure and utilization of its capital ...